Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2025-08-15 00:00:00 ET · period of report 2025-08-13 · accession 0000950170-25-109391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | 2025-08-13 | ALDX | Alfieri Michael | Principal Financial Off | P - Purchase | $5.30 | +2,500 | 2,500 | New | +$13.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-13 | P | A | 2,500 | $5.30 | 2,500 | D | — | — |